Assess Small Molecule Kinetics and Affinity in Just One Step
Fragment-based drug discovery (FBDD) is a popular method for the identification of novel small-molecule drugs. However, traditional FBDD screening methods are based on a primary and a secondary screening.
A new, innovative surface plasmon resonance (SPR) solution provides higher content information, allowing for confident, rapid characterization of hits in a single step.
This application note demonstrates how reliable binding kinetics and affinity can be obtained from one concentration, increasing sample throughput and saving precious material.
Download this application note to discover:
- The importance of kinetic and affinity assessment in drug discovery workflows
- Pre-optimized workflows for robust small-molecule characterization
- How to obtain binding kinetics from one dynamic injection of a single analyte concentration
Brought to you by
Download the Application Note for FREE Now!
Information you provide will be shared with the sponsors for this content.
Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
